191 related articles for article (PubMed ID: 26944315)
1. Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression.
Ma K; Xu Q; Wang S; Zhang W; Liu M; Liang S; Zhu H; Xu N
Cancer Lett; 2016 May; 375(1):84-91. PubMed ID: 26944315
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma.
Huo X; Zhang Q; Liu AM; Tang C; Gong Y; Bian J; Luk JM; Xu Z; Chen J
Oncol Rep; 2013 Feb; 29(2):840-6. PubMed ID: 23232767
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
5. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.
Huang JM; Nagatomo I; Suzuki E; Mizuno T; Kumagai T; Berezov A; Zhang H; Karlan B; Greene MI; Wang Q
Oncogene; 2013 Apr; 32(17):2220-9. PubMed ID: 22689061
[TBL] [Abstract][Full Text] [Related]
6. YAP/TEAD-mediated transcription controls cellular senescence.
Xie Q; Chen J; Feng H; Peng S; Adams U; Bai Y; Huang L; Li J; Huang J; Meng S; Yuan Z
Cancer Res; 2013 Jun; 73(12):3615-24. PubMed ID: 23576552
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.
Bai N; Zhang C; Liang N; Zhang Z; Chang A; Yin J; Li Z; Luo N; Tan X; Luo N; Luo Y; Xiang R; Li X; Reisfeld RA; Stupack D; Lv D; Liu C
Cancer Biol Ther; 2013 Jun; 14(6):511-20. PubMed ID: 23760493
[TBL] [Abstract][Full Text] [Related]
8. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
9. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
10. Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice.
Was H; Barszcz K; Czarnecka J; Kowalczyk A; Bernas T; Uzarowska E; Koza P; Klejman A; Piwocka K; Kaminska B; Sikora E
Oncotarget; 2017 Feb; 8(6):9303-9322. PubMed ID: 28030837
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells.
Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W
Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641
[TBL] [Abstract][Full Text] [Related]
12. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.
Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC
Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051
[TBL] [Abstract][Full Text] [Related]
13. Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549/Taxol cells.
Bai Z; Zhou Y; Ye X; Li Y; Peng Y; Guan Q; Zhang W; Ma L
Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119174. PubMed ID: 34808206
[TBL] [Abstract][Full Text] [Related]
14. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
Qin X; Li J; Sun J; Liu L; Chen D; Liu Y
Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
16. Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions.
Da CL; Xin Y; Zhao J; Luo XD
World J Gastroenterol; 2009 Aug; 15(32):4055-61. PubMed ID: 19705503
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways.
Wen Y; Ji Y; Zhang Y; Jiang B; Tang C; Wang Q; Chen X; Jia L; Gu W; Xu X
Int J Med Sci; 2017; 14(12):1231-1240. PubMed ID: 29104479
[No Abstract] [Full Text] [Related]
18. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
[TBL] [Abstract][Full Text] [Related]
19. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY
PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
